3
Clinical Trials associated with YYC-506Phase 3 Trial to Evaluate the Efficacy and Safety of YYC506.
Phase 3 study to evaluate the effiacay and safety of YYC506
Phase 1 to Evaluate the Safety and Pharmacokinetic Characteristics of Fixed-dose Combination of YYC506
To evaluate the safety and pharmacokinetics characteristics between YYC506 and concomitant administration of YYC506-T and YYC506-A
Phase 1 to Evaluate the Safety and Pharmacokinetic Durg-drug Interaction of YYC506-T and YYC506-A
To evaluate the safety and pharmacokinetics drug-drug interaction of YYC506-T and YYC506-A
100 Clinical Results associated with YYC-506
100 Translational Medicine associated with YYC-506
100 Patents (Medical) associated with YYC-506
100 Deals associated with YYC-506